Patent details

Basic Information

Publication number:

EP2608808

PCT Application Number:

PCT/US/2011/048747

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP118204924

PCT Publication Number:

WO/2012/027324

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT FOR NEOPLASTIC DISEASES

French Title of Invention:

TRAITEMENT DE MALADIES NÉOPLASIQUES

German Title of Invention:

BEHANDLUNG VON NEOPLASIEERKRANKUNGEN

SPC Number:

Dates

Filing date:

23/08/2011

Grant date:

18/01/2017

EP Publication Date:

18/01/2017

PCT Publication Date:

01/03/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/07/2013

EP B1 Publication Date:

18/01/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/08/2017

Expiration date:

23/08/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/08/2011

 

 

Name:

XBiotech Inc

Address:

1055 West Hastings Street, Suite 300, Vancouver, BC V6E 2E9, Canada (CA)

Inventor

Name:

SIMARD John

Address:

United States (US)

Priority

1

Priority Number:

376097 P

Priority Date:

23/08/2010

Priority Country:

United States (US)

2

Priority Number:

406759 P

Priority Date:

26/10/2010

Priority Country:

United States (US)

3

Priority Number:

411183 P

Priority Date:

08/11/2010

Priority Country:

United States (US)

4

Priority Number:

201161480635

Priority Date:

29/04/2011

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/395;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages